Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01354873Completed

Colorectal Polyp Discrimination Using High-Definition Narrow Band Imaging

Role: collaborator

NCT00581581Completed

CoolCap Followup Study-Coordination of Participating Centers

Role: collaborator

NCT00685386Not ApplicableCompleted

A Randomized Controlled Trial (RCT) of Carbon Dioxide Versus Air Insufflation During Endoscopic Retrograde Cholangiopancreatography (ERCP)

Role: collaborator

NCT00383305Not ApplicableCompleted

CoolCap Trial, Treatment of Perinatal Hypoxic-Ischemic Encephalopathy

Role: lead

All 4 trials loaded